Chie Masaki

7PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer.

|Oct 17, 2025
Nuclear STAT3 expression is associated with favorable prognosis in papillary thyroid carcinoma.

Chie Masaki, Tomohiro Chiba, Satoko Baba

|Apr 25, 2025
Clinical characteristics and prognosis of histological subtypes of papillary thyroid carcinoma in pediatric patients.

Junko Akaishi, Kiminori Sugino, Tetsuo Kondo

|Nov 28, 2023
The importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib from the perspective of dose intensity.

Chie Masaki, Junko Shioya, Kiminori Sugino

|Dec 17, 2022
Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study.

Chie Masaki, Kiminori Sugino, Yoshinori Tanizawa

|Jun 23, 2022
Successful dose escalation of lenvatinib for thyroid cancer after disease progression.

Chie Masaki, Kiminori Sugino, Junko Akaishi

Pageof 2

Frequent Collaborators

2 joint publications

Kiminori Sugino

2 joint publications

Tomohiro Chiba

1 joint publications

Junko Akaishi

1 joint publications

Tetsuo Kondo